Lorediplon (Ferrer) | Interleukin Related interleukin-related.com

Product Name :
Lorediplon (Ferrer)

Search keywords :
Lorediplon

drugId :
null

Target Vo:
Gamma-aminobutyric acid A receptor

Target Vo Short Name :
GABAAR

Moa_Name:
Gamma-aminobutyric acid A receptor modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ferrer

Active Company_Name :
Ferrer

Active Indication_Name:
Sleep Initiation and Maintenance Disorders

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cyclin B1 Antibody
VEGFA Antibody
LAMP1 Antibody: LAMP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45 kDa, targeting to LAMP1. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts